Waters to Buy Back Stock | GenomeWeb

NEW YORK (GenomeWeb News) – Waters today said that its board of directors has authorized the firm to repurchase up to $500 million of its outstanding common stock over the next 24 months.

The firm's previous $500 million share repurchase program, which began in February 2007, had recently expired. Waters said that that repurchase program was "substantially completed."

It said that it would make purchases of its shares through open-market transactions.

Waters' shares were trading down 1 percent at $34.70 in early Monday trade on the New York Stock Exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.